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Synthesis and evaluation of bisulfate/mesylate-conjugated 
chlortetracycline with high solubility and bioavailability
The aim of this work is to improve the solubility and bio-
availability of chlortetracycline and the function of the im-
mune response. Chlortetracycline bisulfate and chlortetra-
cycline mesylate were successfully synthesized and 
characterized with several techniques, including spectros-
copy, chromatography and mass spectrometry, which demon-
strated that the C4-dimethylamino group of chlortetra cycline 
can accept a proton from sulfuric acid and methane sulfonic 
acid to form the corresponding salts. In addition, chlortetra-
cycline bisulfate and chlortetracycline mesylate were more 
soluble in water than chlortetracycline hydrochloride, but 
the antibacterial activity was not enhanced. The influences 
of chlortetracycline hydrochloride, chlortetracycline bisul-
fate and chlortetracycline mesylate on chlortetracycline 
and immunoglobulin concentrations in mouse serum were 
also investigated. These results suggested that the chlortetra-
cycline bisulfate and chlortetracycline mesylate have good 
bioavailability and strong immune response and have 
poten tial applications in animal breeding and formulation 
technologies.
Keywords: chlortetracycline, pharmaceutical salt, solubility, 
bioavailability, antibacterial activity, immunoglobulin
Tetracyclines (TCs) are a family of structurally related compounds that include tetra-
cycline (TC), oxytetracycline, doxycycline, minocycline, chlortetracycline (CTC), san-
cycline, and methacycline. CTC, which is the first member of TCs, was discovered by 
Duggar (1). It has a broad spectrum of antibiotic activity against a wide range of Gram-
positive and Gram-negative bacteria, including rickettsiae, enterococci and mycoplasma 
gallisepticum (2, 3). Therefore, it has been widely used in clinical applications to treat a 
variety of infectious microorganisms. TCs are usually used alone to treat diseases at thera-
peutic levels and promote animal growth and feed efficiency at subtherapeutic levels (4, 5); 
additionally, the combination of probiotics could improve nursery pigs’ performance, but 
there were no consistent benefits of feeding them either probiotics alone or in the combina-
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As an animal feed additive, there are two types of CTC products on the market, chlor-
tetracycline hydrochloride (CTC×HCl) and CTC premix (CTC calcium complex), which 
have been used in poultry and livestock industries to promote animal growth and pre-
vent/treat animal diseases. However, shortcomings, such as its poor solubility and low 
bioavailability, have limited the clinical application to some extent (7). Therefore, it is a 
challenge to improve the solubility without compromising the stability and other perfor-
mance characteristics of CTC. One of the common procedures to improve the aqueous 
solubility of a drug is salt formation using a suitable counter ion (8). For example, when 
hexamidine diisethionate was converted to hexamidine dihydrochloride, the solubility 
and stability were improved because the salt is an aromatic diamidine with trypanocidal 
activity (9). Ciprofloxacin and norfloxacin can react with mesylate, gluconate and glycolate 
to form several organic salts to improve their solubility in comparison to that of their 
hydro chloride salts or free fluoroquinolones (10).
CTC contains a 4-ring carbocyclic structure (11), which has multiple ionizable func-
tional groups. The CTC structure contains the tricarbonyl system (C1, C2-CONH2, C3), keto-
phenolic hydroxyl groups (C10-C12) and a dimethylamino group, which cause CTC to 
 undergo protonation-deprotonation reactions depending on the pH of aqueous solutions. 
In addition, CTC has three acid dissociation constants (pKa = 3.3, 7.55 and 9.3). Therefore, 
CTC can be present in its cationic, zwitterionic or anionic form under acidic, moderately 
acidic to neutral or alkaline conditions, respectively (Fig. 1) (12). Hydrochloric acid is com-
monly used to convert organic alkaline drugs to their salts. The dimethylamino group of 
CTC can accept the proton from hydrochloric acid to form the CTC×HCl salt. The reaction 
between an alkaline drug and acid is expected to form a salt if the difference of the base 
and acid, ΔpKa = pKa-base – pKa-acid, is greater than 3. This is well known as a “rule of three”. 
When the ΔpKa value is over 4, the reaction tends to exclusively form salts (13, 14). The ΔpKa 
values between the dimethylamino group (pKa = 9.3) of CTC and hydrochloric acid (pKa = 
–6), sulfuric acid (pKa = –3) and methanesulfonic acid (pKa = –1.2) are equal to 15.3, 12.3 and 
10.5, respectively, which indicates the easy formation of an ionic salt.
Chlortetracycline salts almost always contain small amounts of impurities, such as 
4-epichlortetracycline (4-epiCTC), tetracycline (TC) and 4-epitetracycline (4-epiTC), espe-
cially when they are out-of-date or stored under high temperature and humidity. The bioac-
tivity of these impurities is lower than that of CTC, and their biotoxicity to livestock is 
 increased. Furthermore, these impurities may lead to TCs residues in animal tissues when 
poultry and livestock are treated with TCs (15–21). Anadon et al. (19) reported that mean 
values of CTC plus 4-epiCTC in kidney, liver and muscle tissue were 835.3, 192.7, and 126.3 
μg kg–1, respectively, after 1 day of treatment with CTC in the fattening process of chickens. 
CTC can also be metabolized and transferred to egg albumin and egg yolks from hens (15). 
It was reported that 5 and 9 days were needed to eliminate CTCs in albumin and yolk, 
 respectively, after medicated feed withdrawal (20). Due to the lack of proper guidance for 
use, the majority of TCs are excreted to the environment through urine and feces, and most 
CTCs are retained in the manure or soil directly beneath the manure application site (22). 
CTC retained in the soil can be taken up by plants (23, 24) and has a negative effect on soil 
enzyme activities, including those of urease and dehydrogenase (25). Moreover, it could be 
a potential threat to human health when meats and plants contaminated with TCs are eaten.
In this study, two new CTC salts were synthesized using sulfuric acid and methane-
sulfonic acid. The structures of the two newly synthesized salts were characterized by 
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high-performance liquid chromatography (HPLC), ion chromatography (IC), thermal 
analysis and spectroscopy. The solubility of the new salts was compared with that of 
CTC×HCl and their antibiotic activities were investigated with Gram-negative and Gram- 
-positive bacteria. The in vivo responses of the immune system to CTC×HCl, chlortetracy-
cline bisulfate (CTC×H2SO4) and chlortetracycline mesylate (CTC×CH3SO3H) were also 
tested. The results showed a high bioavailability of CTC×H2SO4 and CTC×CH3SO3H in in 
vivo models for oral absorption as we expected.
EXPERIMENTAL
General
Differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA) of 
CTC salts were performed with a NETZSCH DSC 404 F3 Pegasus® equipped with a refrige-
rated cooling system (liquid nitrogen cooling) (Germany). The CTC salts (5 ± 0.01 mg) 
were heated in aluminum sample holders and scanned at 10 °C min–1 in the range of 50–
500 °C under a nitrogen atmosphere. The data were analyzed by Proteus® software. 1H 
nuclear magnetic resonance (1H NMR) spectra were acquired using an Agilent-NMR-
vnmrs600 instrument. The CTC salts were dissolved in dimethyl sulfoxide-d6 (DMSO-d6) 
with tetramethylsilane (TMS) as a reference. The conventional powder X-ray diffraction 
(PXRD) method was used for qualitative phase analysis. A Rigaku D/Max2500pc diffrac-
tometer was used with Cu radiation. The maximum wattage was 18 kW. The voltage and 
amperage of the Cu tube were set at 40 kV and 150 mA, respectively. Solid CTC salts were 
scanned between 10° and 90° in 2θ with a rate of 4° min–1. The ultraviolet-visible (UV) 
absorption spectra were recorded over 200–500 nm with a Shimadzu UV1800. The infrared 
(IR) spectra of CTC×HCl, CTC×H2SO4 and CTC×CH3SO3H were recorded over the region 
of 400-4000 cm–1 with a Braic WQF-510A spectrophotometer. The samples were examined 
in KBr pellets. A mass spectrometer (MS) (Waters Acquity SQ Detector) equipped with an 
ESI source was used in both positive and negative ion modes. The solid CTC×HCl, 
CTC×H2SO4 and CTC×CH3SO3H salts were dissolved in methanol. The electrospray volt-
age was 2.8 (+/–) kV, and the desolvation temperature was 400 °C. The cone gas flow rate 
and desolvation gas flow rate were set at 55 and 550 L h–1, respectively.
CTC×HCl was a gift from Pucheng Chia Tai Biochemistry Co. Ltd. (Fujian, China). 
Sulfuric acid was purchased from Eagle Chemical Reagent Co. Ltd. (Zhejiang, China). 
Methanesulfonic acid, isopropyl alcohol and 2-ethoxyethanol were purchased from Kelong 
(Chengdu, China) and stored in the dark environment. Methanol, ethanol and n-butanol 
were obtained from Chuandong Chemical Co. Ltd. (Chongqing, China). All other reagents 
for reactions and chromatography experiments were of analytical grade or HPLC grade.
Synthesis
Preparation of CTC neutral base. – CTC×HCl (8 g) was added to 1000 mL of water and the 
mixture was stirred for 30 min at 18 °C. The undissolved impurities were removed from 
the solution by filtration. Then, the pH of the solution was adjusted to 4.2 to obtain the 
precipitation of the CTC neutral base while the slurry was stirred for 1 h. Finally, the solu-
tion was filtered and further washed with water and ethanol to obtain the CTC neutral 
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base. The CTC neutral base was dried under vacuum at room temperature for 48 h. The 
yield of the CTC neutral base was 87.9 ± 1.8 %.
Preparation of CTC×H2SO4. – First, 5 mL of sulfuric acid (50 % m/V, ethylene glycol solu-
tion) was slowly added to 10 mL of a 2-ethoxyethanol and ethylene glycol (1:1) mixture 
solution that was chilled at 15 °C. After that, 5 g of the CTC neutral base was added to the 
solution, and the mixture was magnetically stirred for 2 h at 15 °C. Then, 20 mL of n-buta-
nol was added, and the mixture was stirred for 15 min for crystallization. The reaction 
mixture was left at 4 °C for 2 h before filtration. The filtered product was further washed 
twice with n-butanol and once with isopropanol, and then dried under vacuum at room 
temperature for 48 h to obtain CTC×H2SO4, representing a yield of 64.6 ± 5.5 %. A scanning 
electron microscopy (SEM) micrograph of CTC×H2SO4 is shown in Fig. 2a.
Preparation of CTC×CH3SO3H. – Two milliliters of 50 % methanesulfonic acid in  methanol 
was slowly added to 8 mL of methanol that was chilled at 15 °C. Then, 5 g of the CTC 
 neutral base was added to the solution, and the mixture was magnetically stirred for 1 h 
at 15 °C. Afterwards, 10 mL of ethanol was added, and the mixture was stirred for 20 min 
for crystallization. After chilling at 4 °C for 2 h, the mixture was filtered, washed twice 
with ethanol and dried under vacuum for 48 h at room temperature to obtain the final 




Reference substances of CTC (purity, 94.2 %), 4-epiCTC (purity, 90.1 %), TC (purity, 97.1 
%) and 4-epiTC (purity, 86.8 %) were purchased from the National Institutes for Food and 
Drug Control (China). To obtain the stock standard solutions, reference substances were 
dissolved in 0.01 mol L–1 hydrochloric acid and stored at 4 °C for 1 week before use. Stan-
dard solutions of CTC×H2SO4 and CTC×CH3SO3H were diluted in 0.01 mol L–1 hydrochloric 
acid. The CTC salts and impurities (4-epiCTC, TC, 4-epiTC) were measured using HPLC 
(Agilent 1260, USA) equipped with a C8 column (phenimenex, Luna 5u C8(2) 100A, 150 × 
4.60 mm). HPLC analysis was performed following the techniques recommended by the 
product quality standard of chlortetracycline hydrochloride (CVP) (Q/PZSH 03-201), 
which was formulated by the Chia Tai Group. The ultraviolet detection wavelength was 
280 nm, and the injection volume was 20 μL.
IC analysis
To estimate the anion concentrations of CTC×H2SO4 and CTC×CH3SO3H, solid CTC 
salts were dissolved in deionized water. Standard solutions of 5, 10, 20 and 40 μg mL–1 
hydrochloric acid, sulfate acid and methanesulfonic acid were prepared by diluting the 
corresponding stock solutions. Then, the solution of CTC salts was filtered through a 0.22 
μm filter. The ion chromatography (ICS-5000, ThermoFisher, USA) was equipped with a 
self-regenerating suppressor (Dionex ASRS 300, 4 mm) and a conductive detector and was 
used for determination of dissolved sulfate ions of the CTC×H2SO4 and the mesylate ions 
of the CTC×CH3SO3H. An anion analytical column (Dionex IonPac AS11-HC, 250 × 4 mm) 
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was used for separation. A 30 mM NaOH solution was used as the mobile phase with a 
flow rate of 1 mL min–1.
Solubility tests
An excess amount of CTC salt was added to water in an EP test tube for the determina-
tion of solubility. The test tube was placed in a thermostatically controlled water bath and 
vortexed with a Stuart Vortex Mixer SA8 (Bio Cote, U.K.) every 5 min. The mixture was 
equilibrated for 30 min at 25 °C to obtain a saturated solution. Then, the mixture was cen-
trifuged with an Eppendorf 5430R centrifuge (Eppendorf, Germany) at 5000 rpm for 5 min 
at 25 °C. Finally, the supernatant was diluted, and the concentration of the active com-
pound was measured using HPLC.
Biological evaluations
Antibacterial activity. – CTC×HCl, CTC×H2SO4 and CTC×CH3SO3H were tested for 
growth inhibitory activity against the bacteria Bacillus cereus ATC11778, Staphylococcus au-
reus ATCC6538 and Escherichia coli ATCC11775 in vitro. The final concentrations of the an-
tibiotics were 1.07 × 10–1, 5.36 × 10–2, 2.68 × 10–2, 1.34 × 10–2, 6.70 × 10–3, 3.35 × 10–3, 1.67 × 10–3, 
8.37 × 10–4, 4.18 × 10–4, 2.09 × 10–4, 1.05 × 10–4 and 5.23 × 10–5 μmol mL–1. Bacterial strains were 
cultured in nutrient broth at 37 °C. The growth was recorded after incubation for 24 h and 
48 h to test the minimal inhibitory concentration (MIC) and minimum bactericidal concen-
tration (MBC), respectively.
Immune regulation in vivo. – A total of 56 SPF level Kunming mice (KM) were ran-
domly assigned to one of seven groups. The control group did not receive any treatment 
and was used to determine the validation criteria of any analytical method. The treatment 
groups of CTC×HCl, CTC×H2SO4 and CTC×CH3SO3H were fed orally with CTC at a nomi-
nal dosage of 50 mg/kg BW/day for 42 consecutive days. Blood samples were collected from 
the eyes of the mice after 21 and 42 days. All blood samples were centrifuged with an Ep-
pendorf 5430R centrifuge (Eppendorf, Germany) at 2000 rpm for 12 min, and the superna-
tant serum was harvested and stored at –20 °C until analysis. The concentration of CTCs 
in serum was analyzed with a CTC ELISA kit (Reagen, RND 99050). The immunoglobulin 
(IgM, IgG and IgA) levels in the serum of mice treated with CTCs were analyzed. All 
ELISA kits were purchased from Abcam (ab133047 IgM Mouse ELISA kit v2, ab157719 IgG 
Mouse ELISA kit v2 and ab157717 IgA Mouse ELISA kit v3).
RESULTS AND DISCUSSION
Identification of the interaction between CTC and acids
The structures of the new CTC salts were confirmed by 1H NMR, PXRD, UV, IR, MS 
and thermal analysis, and the data are given in Table I. The atom numbering used in the 
current study is indicated in Fig. 1.
The 1H NMR spectra of the different CTC salts displayed intense resonances near 2.9 
ppm attributable to the common C4-dimethylamino group (26). The N-protonation led to a 
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pronounced downfield shift of N-methyl resonances from 2.6 to 2.9 ppm in CTC. The six 
protons of the C4-dimethylamino group in the hydrochloride salt were observed as a single 
peak that occurred at 2.859 ppm. These protons were split into multiple peaks in the sulfate 
and mesylate salts in the field near 2.859 ppm. The chemical shift of the ammonium proton 
was at a higher field because the proton was in the deshielded area. The absorption of C3-
hydroxyl was appeared as a broad peak, near 16.3 ppm. The chemical shift of the ammo-
nium proton in CTC×HCl, CTC×H2SO4 and CTC×CH3SO3H was 10.510, 9.866 and 9.855 
ppm, respectively (Fig. S1), because the different anions affected the electromagnetic envi-
ronment of the ammonium proton differently. For the CTC salts, proton transfer from 
sulfuric acid and methanesulfonic acid to the N-atom of the dimethylamino group were 
easily recognized. The C2-amide protons of CTC×HCl had broad resonances at 9.1 and 9.5 
ppm, which was in agreement with the same observation for the chemical shift in the 
spectra of the CTC×H2SO4 and CTC×CH3SO3H compounds. This could have implied that 
the amide group did not participate in the salt formation reactions. For the C10-C12 keto-
phenolic hydroxyl groups, the C10- and C12-hydroxyl protons were intramolecularly hydro-
gen-bonded to the nearby carbonyl oxygen at C11 and C1, respectively (26). The chemical 
shifts of the C10 and C12 aromatic enols were 12.1 and 15.0 ppm, respectively. CTC×CH3SO3H 
had a signal resonance related to S-CH3 protons at 2.295 ppm. A broad peak was observed 
at 3–4 ppm for CTC×H2SO4, which indicated the fast exchange rate of free H+ from HSO4–
and H2O.
The UV spectra show that the three salts had the same peaks (λmax) and troughs (λmin) 
(Table I and Fig. S2). The IR spectrum of the CTC×HCl molecule exhibited absorptions as-
sociated with the amide group at ring A, the amide III band was at 1672 cm–1 ν(C=O), the 
amide II band was at 1621 cm–1 ν(N-H) and the amide III band was at 1413 cm–1 ν(C=N) (Fig. 
S3). These bands were also observed for the newly synthesized salts at similar wavenum-
bers, i.e., the CTC×H2SO4 and CTC×CH3SO3H amide bands were observed at 1661, 1615, and 
1409 cm–1 and 1664, 1615, 1410 cm–1, respectively. The vibrational bands of hydroxyl and 
amide NH2 groups were visible at 3305 cm
–1, and this was also observed in CTC×H2SO4 
and CTC×CH3SO3H as a band at 3392 and 3396 cm–1, respectively. The modifications 
 observed in the CTC×H2SO4 and CTC×CH3SO3H spectra were similar to those in that of 
CTC×HCl, although the sulfate anions and mesylate anions had unique absorption peaks. 
The absorption of the antisymmetric stretching vibration of the inorganic SO4
2– group at 
1120 cm–1 νa(SO42–) indicated a strong stretching vibration. On the other hand, symmetric 
stretching vibration in the wavenumber of 1000–950 cm–1 indicated a weak stretching vi-
Fig. 1. Chemical structure of CTC and the pKa values.
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bration. The asymmetric angle vibration and symmetric angle vibration had weak absorp-
tions at 619 and 460 cm–1, respectively. The three oxygen atoms in the mesylate of 
CTC×CH3SO3H were equivalent, but there were antisymmetric stretching vibrations and 
symmetric stretching vibrations for SO3; the two vibrations were observed at 1206 (strong) 
and 1047 cm–1 (medium), respectively. The ν(C-Cl) of ring D overlapped with the symmet-
ric stretching vibration of ν(SO3).
MS has become an effective detection technique due to its high sensitivity and selec-
tivity (27). The fragment of CTC was obtained with the ESI interface in both positive and 
negative ion modes. The MS fragments of CTCs were investigated in both positive and 
negative ion modes (Fig. S4 and S5). In positive ion mode, the loss of NH3 and H2O from 
[M + H]+ ions was in agreement with previous studies (16, 28). The protonated molecular 
ions of CTC×HCl, CTC×H2SO4 and CTC×CH3SO3H produced three different product ions 
[M + H – NH3]
+ at m/z 462, [M + H – H2O]+ at m/z 461 and [M + H – NH3 – H2O]+ at m/z 444, 
respectively (Table I and Fig. S6) (29). In negative ion mode, mesylate ions and hydrogen 
sulfate ions were observed at m/z 95 and m/z 97 (Fig. S5), respectively, which demonstrated 
their presence in the new salts. In CTC, the amide group of ring A can result in a loss of 
the NH3 group; on the other hand, the C6 position of ring C can result in a loss of H2O 
because of the lower energy process (30). An elimination reaction can occur between the 
C6-hydroxyl and C5a-proton groups with a loss of H2O, resulting in an aromatic naphtha-
lene ring structure. It is likely that the presence of the Cl at position C7 in ring D rendered 
the loss of H2O from the adjacent C6 position of ring C, which demanded more energy and 
resulted in a higher abundance of [M + H – NH3]
+ compared to that of [M + H – H2O]
+ for 
CTC (16). The fragmentation pattern of CTC suggested a loss of the NH3 group first and 
then a loss of H2O.
PXRD was used to confirm the formation of the different CTC salts. The PXRD pattern 
for CTC×HCl was identical to the reported PXRD pattern for polymorphic form α (31). The 
diffraction peaks of CTC×HCl, CTC×H2SO4 and CTC×CH3SO3H are presented in Fig. 3 and 
Tables S1-3. In the case of the salts, the major peaks were distinctive among CTC×HCl, 
CTC×H2SO4 and CTC×CH3SO3H. This result was in agreement with the thermal analysis 
of the salt, indicating the formation of new solid phases.
Fig. 4 shows the results of the DSC and TGA results of the different CTC salts. The 
small mass loss (0.69 %) in the temperature range of 25–230 °C might be attributed to the 
Fig. 2. SEM of: a) CTC×H2SO4 and b) CTC×CH3SO3H. The scale bar is 100 μm.
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loss of absorbed water and other volatiles. However, degradation was observed in the 
temperature range of 230–300 °C. Only 58.4 % of the initial mass of CTC×HCl remained at 
400 °C. The DSC curve in Fig. 4a shows that the exothermic peak could be assigned to the 
decomposition of the CTC structure. The first endothermic peak of CTC×H2SO4 in the DSC 
curve could be ascribed to dehydration, which could be evidence to prove the presence of 
water molecules in the CTC×H2SO4 structure. This result was in agreement with those of 
TGA analysis, which exhibited a mass loss of 3.17 % between 25 and 55 °C (Fig. 4b). The 
degradation occurred between 200 and 250 °C, and only 58 % of the initial mass of 
CTC×H2SO4 remained at 400 °C. For the DSC curve, there was an endothermic event with 
a melting temperature of 199–202 °C, reflecting the melting of an unhydrated structure of 
CTC×H2SO4. The consecutive exothermic decomposition event could be assigned to the 
decomposition of CTC. For CTC×CH3SO3H, there was also a slight mass loss between 25 
and 200 °C, and only 59 % of the initial mass remained at 400 °C (Fig. 4c). A degradation 
process was observed in two stages between 200 and 350 °C. The endothermic event at 
Fig. 3. PXRD of CTC×HCl, CTC×H2SO4 and CTC×CH3SO3H.
Table II. The mass fractions of CTC, TC, 4-epiCTC, 4-epiTC and acid determined with HPLC and IC methods
Salt
Mass fraction (%)
CTC TC 4-epiCTC 4-epiTC Acid (theory)
CTC×HCl 83.91 ± 1.77 3.18 ± 0.02 3.01 ± 0.07 0.06 ± 0.00 7.14 ± 0.38 (6.86)
CTC×H2SO4 71.69 ± 2.26 1.67 ± 0.08 5.46 ± 0.76 0.11 ± 0.00 16.55 ± 2.02 (16.16)
CTC×CH3SO3H 76.76 ± 1.75 1.40 ± 0.02 0.87 ± 0.01 0 15.47 ± 0.48 (15.86)
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Fig. 4. DSC and TGA curves of: a) CTC×HCl, b) CTC×H2SO4 and c) CTC×CH3SO3H in an N2 atmosphere.
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199–200 °C could reflect the melting point of CTC×CH3SO3H. For all of the salts, melting 
was immediately followed by decomposition. The three CTC salts also had different melting 
points. The degradation point might confirm the formation of the new salts. Only a 40 % 
mass loss was observed for the three salts with the same CTC cation by the time the tempe-
rature reached 400 °C under an N2 environment. CTC contains a 4-ring structure and 
therefore could not be degraded at temperatures up to 400 °C. The thermal degradation of 
CTC can release dimethylamine, water, isocyanic acid, methane, ammonia and carbon 
dioxide from the decomposition of isocyanic acid (32). In stoichiometry, the asymmetric 
unit of CTC×H2SO4 contains a CTC cation, a sulfate anion and one molecule of crystal 
water. The asymmetric unit of CTC×CH3SO3H includes one CTC cation and one mesylate 
anion, which suggests that CTC×CH3SO3H is an unhydrated CTC salt.
Quantitation analysis
HPLC has been successfully used for the quantitation of CTCs in the samples (33). 
CTC and its derivatives were separated on a C8 column with a retention time of 4.5 min 
for 4-epiTC and 5.0 min for TC (Fig. S7). In contrast, 4-epiCTC and CTC were well sepa-
rated with retention times of 8.6 min and 10.1 min, respectively. Table II lists the quantifica-
tion results for CTCs and their derivatives. The ω(4-epiCTC) of CTC×H2SO4 (5.46 %) was 
higher than that of CTC×HCl (3.01 %), but the ω(TC) decreased from 3.18 % for CTC×HCl 
Fig. 5. Effect of oral CTC treatment on serum: a) CTC concentration and b) immunoglobulin IgM, 
c) IgA and d) IgG) levels in mice. t-test: *indicates significant difference (p < 0.05), **indicates highly 
significant difference (p < 0.01).
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to 1.67 % for CTC×H2SO4. Moreover, the ω(4-epiCTC) of CTC×CH3SO3H (0.87 %) was lower 
than that of CTC×HCl (3.01 %), and the ω(TC) slightly decreased from 3.18 % for CTC×HCl 
to 1.40 % for CTC×CH3SO3H. The concentrations of ω(4-epiTC) in different CTC salts were 
negligible. Overall, the concentrations of derivatives in CTC×CH3SO3H and CTC×H2SO4 
were all decreased, but the 4-epiCTC in CTC×H2SO4 was slightly higher. The linearity of 
the chromatographic procedure was checked by analyzing a CTC reference substance in 
the concentration range of 0.1–2 mg mL–1. The correlation coefficients of the calibration 
curves were above 0.99, indicating a linear calibration curve.
IC with high sensitivity is suitable for the analysis of anions (the hydrochloride ion, 
sulfate ion and mesylate ion) at low concentrations in samples (34, 35). The anions chloride, 
sulfate and mesylate were separated with retention times of 3.8, 4.8 and 3.2 min, respec-
tively (Fig. S8). The resolution for the three peaks was good. The results showed that there 
was only one anion in each of the CTC×H2SO4 and CTC×CH3SO3H products. Linearity was 
evaluated for chloride, sulfate and mesylate in the range of 5–40 μg mL–1 (y = 0.0945x – 0.0532, 
R2 = 0.9987; y = 0.0999x – 0.1338, R2 = 0.9993 and y = 0.0423x – 0.056, R2 = 0.9997, respectively).
In this paper, we measured the anion concentration of different CTC salts. The results 
showed that the percentages of acid in terms of mass for CTC×HCl, CTC×H2SO4 and 
CTC×CH3SO3H were 7.14, 16.55 and 15.47 %, respectively, which was in agreement with the 
theoretical anion composition of the different CTC salts. As a result, it was reasonable to 
conclude that the molar ratios of CTC to acid in CTC×H2SO4 and CTC×CH3SO3H were 1:1 
and 1:1, respectively.
The solubility of CTC×HCl, CTC×H2SO4 and CTC×CH3SO3H in the water at 25 °C was 
measured and is outlined in Table I. The table shows that CTC×H2SO4 and CTC×CH3SO3H 
were more soluble in water than CTC×HCl. The table also shows a significant difference in 
the solubility among CTC×HCl, CTC×H2SO4 and CTC×CH3SO3H (p < 0.01).
Biological evaluation
The MIC and MBC of CTC×HCl, CTC×H2SO4 and CTC×CH3SO3H are outlined in Table 
III. The three salts had the same MIC for Bacillus cereus, Staphylococcus aureus and Escherichia 
coli, and the concentrations were 1.05 × 10–4, 8.37 × 10–4 and 5.36 × 10–2 μmol mL–1, respec-
tively. Interestingly, the MBC of the three salts for Escherichia coli was the same as the MIC. 
This could demonstrate that the Escherichia coli had been dead after 24 h of incubation.








Bacillus cereus 1.05 × 10–4/4.18 × 10–4 1.05 × 10–4/4.18 × 10–4 1.05 × 10–4/4.18 × 10–4
Staphylococcus 
aureus 8.37 × 10
–4/6.70 × 10–3 8.37 × 10–4/6.70 × 10–3 8.37 × 10–4/6.70 × 10–3
Escherichia coli 5.36 × 10–2/5.36 × 10–2 5.36 × 10–2/5.36 × 10–2 5.36 × 10–2/5.36 × 10–2
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We measured the concentration of CTCs in mouse serum after 21 and 42 days. The 
results showed that the CTC concentrations in serum collected from mice treated with 
CTC×H2SO4 and CTC×CH3SO3H were significantly higher than those treated with 
CTC×HCl at both 21 and 42 days (Fig. 5a). This demonstrated that CTC×H2SO4 and 
CTC×CH3SO3H had better bioavailability due to their higher solubility than that of 
CTC×HCl. No CTCs were found in the control group. Linearity was evaluated with CTC 
concentrations in the range of 0.05–1.6 ng mL–1 (y = –33.309x + 33.938, R2 = 0.9967).
Considering that antibiotics could influence the immunity of organisms, the IgM, IgA 
and IgG levels in serum were evaluated after the mice were treated with CTCs. The results 
showed that the concentrations of the IgM antibody in the treated groups were lower than 
in the control group after 21 days (p < 0.01) (Fig. 5b). Interestingly, the IgM antibody con-
centrations in the groups treated with CTC×H2SO4 and CTC×CH3SO3H significantly 
 increased compared with that in the control group, and the CTC×HCl-treated group showed 
similar results after administration for 42 consecutive days (p < 0.01). The IgM antibody 
concentration in the CTC×HCl-treated group increased to normal levels without a signifi-
cant change compared with that of the control group (p > 0.05). The IgA antibody concen-
trations in the CTC×H2SO4 treated group was lower than that in the control group (p < 0.01) 
after 21 days, but the IgA antibody concentrations in the CTC×HCl- and CTC×CH3SO3H- 
-treated groups showed no obvious reduction compared with that in the control group (p 
> 0.05) (Fig. 5c). However, the IgA antibody concentration in all three treated groups de-
creased significantly (p < 0.01) after 42 days compared with that in the control group. Con-
sidering the negative effects of sustaining a low dose of CTC salts, the significant decrease 
in IgA antibody concentration after 21 days for the CTC×H2SO4-treated group might have 
resulted from the high serum CTC concentration. The IgG antibody concentration in all 
treated groups was not significantly different from that in the control group after 21 and 
42 days (p > 0.05) (Fig. 5d). Interestingly, the IgG antibody concentration in the CTC×H2SO4-
treated group showed an increase from 21 to 42 days (p < 0.05). The immunoglobulin 
standard curves were made with four parameters logistic curve fitting, and the correlation 
coefficients of the calibration curves were above 0.99. The standard curves of IgM, IgA and 
IgG were y = 9.74206 + (0.02568 – 9.74206)/(1 + (x/1402.73488)^0.88258), R2 = 0.99943; y = 1.4652 
+ (–20.19055 – 1.4652)/(1 + (x/0.24642)^0.85859), R2 = 0.99687 and y = 4.80936 + (0.03013 – 
4.80936)/(1 + (x/206.13394)^0.86599), R2 = 0.99897, respectively.
TCs could inhibit the acquired immune system and innate immune system defenses, 
such as phagocytes and complement, T and B lymphocytes (36). Nikolov et al. (37) found 
that TCs inhibit immunoglobulin antibody formation in spleen cells, especially when 
treated with CTCs. In accordance with their results, the concentrations of IgM and IgA 
antibodies in serum collected from the treated groups both decreased after 21 days, which 
suggested that immunocompetence for antibodies in mice could be decreased by CTCs. 
Our results also showed that the concentration of IgM significantly increased in both the 
CTC×H2SO4-treated group and the CTC×CH3SO3H-treated group after 42 days compared 
to that of the control group. In contrast, the IgA concentration had a further reduction after 
42 days. The change in IgG concentration was not obvious during the whole treatment 
duration. In addition, CTC×H2SO4 and CTC×CH3SO3H had higher bioavailability than that 
of CTC×HCl. Overall, the modulation of IgM, IgA and IgG antibodies by supplementation 
with CTCs might be related to physical health and production parameters.
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CONCLUSIONS
This study set out to improve the solubility and bioavailability of CTC, and CTC×H2SO4 
(CTC:H2SO4:H2O = 1:1:1) and CTC×CH3SO3H (CTC:CH3SO3H = 1:1) were synthesized, 
whose molecular ratio and structure were also characterized. HPLC and IC chromatogra-
phy were used to analyze the cation and anion concentrations in the new salts, and the 
results further confirmed the mole ratio of CTC to the salt anion. The thermal analysis 
confirmed that CTC×H2SO4 had one mole of crystal water and CTC×CH3SO3H had no  water 
in their new salts. The PXRD results demonstrated that CTC×H2SO4 and CTC×CH3SO3H 
were new crystals. The solubility of CTC×H2SO4 and CTC×CH3SO3H improved by 53 and 
44 times in water, respectively, when compared with that of CTC×HCl. The CTC concentra-
tions in serum collected from the treated mice were significantly increased in both the 
CTC×H2SO4- and CTC×CH3SO3H-treated groups compared to that in the CTC×HCl-treated 
group, which indicated improvement of their bioavailability. In addition, the CTC×H2SO4- 
and CTC×CH3SO3H-treated groups exhibited a strong immune response. In conclusion, 
our results suggest that CTC×H2SO4 and CTC×CH3SO3H are more effective than CTC×HCl, 
although there is no difference between their antibiotic activities. Evaluation of their bio-
availability, pharmacology and toxicology should be completed in experiments with poul-
try and livestock model animals.
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